PALINGEN INC has a total of 23 patent applications. Its first patent ever was published in 1998. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are THRASOS THERAPEUTICS INC, HISTATEK LLC and THRASOS INNOVATION INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Australia | 4 | |
#3 | Canada | 3 | |
#4 | Brazil | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Mexico | 2 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Sanders Martin E | 14 |
#2 | Bhat Neelima M | 11 |
#3 | Teng Nelson N H | 9 |
#4 | Bieber Marcia M | 9 |
#5 | Marcia M Bieber | 5 |
#6 | Martin E Sanders | 5 |
#7 | Neelima M Bhat | 5 |
#8 | Nelson N H Teng | 5 |
#9 | Teng Nelson H | 2 |
#10 | Bieber Marica M | 2 |
Publication | Filing date | Title |
---|---|---|
WO2007092427A2 | Treatment of endotoxemia using endotoxin neutralizing agents | |
WO2007035857A2 | Treatment of b cell diseases using anti-germline antibody binding agents | |
MX2007005320A | Antibody induced cell membrane wounding. | |
CA2542886A1 | Enhanced b cell cytotoxicity of cdim binding antibody | |
AU7977098A | Method for diagnosing systemic lupus erythematosus |